Background: Although gross vascular invasion (VI) has prognostic significance in patients with 23 hepatocellular carcinoma (HCC) who have undergone hepatic resection, few studies have investigated 24 the relationship between gross VI and aberrant expression of microribonucleic acids (miRNAs and 25 miRs). Thus, the objective of this study was to identify miRNAs selectively expressed in HCC with 26 gross VI and investigate their prognostic significance. 27 Materials and Methods: Eligible two datasets (accession number: GSE20594 and GSE67140) were 28 collected from the National Center for Biotechnology Information's (NCBI) Gene Expression 29 Omnibus (GEO) database to compare miRNAs expression between HCC with and without gross VI. 30 Differentially expressed miRNAs were externally validated using expression data from The Cancer 31 Genome Atlas (TCGA) database. Prognostic significance and predicted functions of selected miRNAs 32 for HCC were also investigated.
Introduction 50
Hepatocellular carcinoma (HCC) has received increasing attention because of its frequent diagnosis 51 worldwide with a dismal prognosis [1] . Although various curative or palliative therapeutic modalities 52 have been administered, long-term outcomes of patients with HCC have remained poor [2] . A 53 significant contributor to poor outcomes is the tendency of HCC toward vascular invasion (VI) which 54 reflects the tumor's aggressiveness [3, 4] . Therefore, altered or disrupted regulatory mechanisms 55 contributing to VI in tumor cells a barrier to overcoming this cancer and so are candidate targets for a 56 new therapeutic trial. These targets should be distinct genetic or pathologic features of HCC with VI 57 definitely different from those of HCC without VI. 58 It is well known that unique gene expressions are highly related to tumor progression [5] . 59 meaningful negative correlations (r < −0.3 and FDR < 0.05). Cancer Hallmarks Analytics Tool 139 (CHAT) was used to figure out the association between selective miRNAs and documented evidence 140 of these in hallmarks of cancer [20] . 141 142 Results 143 miRNA differential expression analysis 144 As described in the detailed flowchart shown in Fig 1a, in this study, we obtained information about 145 expression levels of miRNAs from NCBI GEO database [15] . To screen miRNAs that were 146 significantly more or less abundant in HCC with VI compared to those in HCC without VI, we 147 performed differential expression analysis by comparing the expression level of each miRNA from 148 two microarray datasets (accession number: GSE20594 and GSE67140). These datasets included 31 149 samples of HCC without gross VI vs. 46 samples of HCC with gross VI (accession number: 150 GSE20594) and 91 samples of HCC without gross VI vs. 81 samples of HCC with gross VI 151 (accession number GSE67140). We then identified differentially expressed miRNAs based on the 152 Wilcoxon ranked-sum test and the RankProd method [16] . A total of 49 miRNAs in GSE20594 were 153 upregulated in HCC with VI compared to those in HCC without VI. In addition, 185 miRNAs in 154 GSE67140 showed increased expression levels in HCC with VI compared to those in HCC without 155 VI. Ten miRNAs were upregulated in these two microarray data sets. Forty-one miRNAs (GSE20594) 156 and 184 miRNAs (GSE67140) were downregulated in HCC with VI compared to HCC without VI We found no miRNA expression data for 5 of 377 patients with HCC in the TCGA LIHC database.
162
The remaining 372 patients were divided into three groups by gross VI status as follows: group A (n = 163 206), patients with HCC without gross VI; group B (n = 17), patients with HCC and gross VI; and 164 group C (n = 149), patients with HCC with McVI or patients for whom no gross VI status was 165 available. Groups A and B were included in the study to find miRNAs expressed differentially 166 between HCC with and without VI. Group C was included in survival analysis according to 167 expression value of each candidate miRNA.
168 Table 1 summarizes clinical characteristics of groups A, B, and C. Group B had slightly 169 higher preoperative platelet counts without statistical significance (P = 0.058). However, the 170 percentage of patients who had undergone major hepatic resection was significantly lower (P < 171 0.001). Besides these differences, these three groups were comparable. The overall median follow-up 172 period was 16 months (range, 0-122 months). Survival analysis showed significantly worse RFS (1-173 year RFS rates: group A, 75.7%; group B, 50.0%; P = 0.033) and OS (2-year OS rates: group A, 174 75.4%; group B, 50.3%; P = 0.036) for patients with HCC and gross VI (Fig 1c) . 3~4 9 ( 6.5%) 0 ( 0.0%) 9 (10.3%) 0.001, P = 0.024, and P = 0.009, respectively) and worse OS (log-rank test: P < 0.001, P = 0.002, and 208 P < 0.001, respectively) (Table 2) . However, miR-99a-5p underexpression showed a significant 209 difference in OS outcome (log-rank test: P < 0.001), but not in RFS outcome. recurrence with types of surgery (P < 0.001) and advanced TNM stage (P < 0.001). Multivariate logistic regression was performed for each predictor of recurrence, including gross VI, miR-100-5p 219 underexpression, and miR-582-3p overexpression. We found that types of surgery (HR = 1.676; 95% 220 CI: 1.205-2.332; P = 0.002), advanced TNM stage (HR = 1.795; 95% CI: 1.266-2.547; P = 0.001),
221
and miR-100-5p underexpression (HR = 1.511; 95% CI: 1.041-2.194; P = 0.029) remained 222 significant independent risk factors for tumor recurrence (Fig 3) . Types of surgery, concomitant viral 223 hepatitis, and advanced TNM stage were associated with poorer OS in univariate Kaplan-Meier 224 survival estimation with log-rank comparisons (P = 0.024, P = 0.019, and P < 0.001, respectively).
225
The multivariate proportional hazards model identified that types of surgery (HR = 1.844; 95% CI: after hepatic resection in HCC (Fig 3) . Fig 4b) . There was no available dataset for finding 250 targets of either miR-148a or miR-582-3p from NCBI GEO database. affected by all three miRNAs (Fig 4c) . 
Discussion
In this study, we used publicly available data from TCGA repositories to find specific miRNAs 266 associated with gross VI in HCC. We found that down-regulation of miR-99a/-100/-148a and up- presence of gross VI. To the best of our knowledge, no previous study has investigated the association 276 between aberrant expression of these four miRNAs (miR-99a, miR-100, miR-148a, and miR-582) and 277 gross VI in HCC tissue samples.
278
Gross VI is a well-known factor that contributes to tumor recurrence and poor prognosis. A 279 recent study has reported that its prevalence in newly detected HCC is 35% [23] . Notably, gross VI is 280 found to be a major prognostic factor following hepatic resection for HCC [24] . Unfortunately, the 281 optimal treatment strategy for HCC with gross VI remains inconclusive. gross VI. In the near future, it is likely that newly discovered molecular targets based on the TCGA 330 database will be applied to clinical cancer practice, including for early detection, treatment, and even 331 prevention of cancers. However, effective translation of cancer genomics or proteomics to clinical 332 practice requires progress in analytics, which in turn, requires close cooperation between 333 bioinformaticians, mathematicians, and oncologists.
334
A limitation of our study was that it was based on secondary data analysis. Therefore, there 335 was a lack of information about important perioperative data such as liver enzyme profiles, antiviral 336 drug use, and postoperative progression of underlying liver disease. These are believed to influence 337 tumor recurrence and de novo malignancy. Additionally, data on tumor size and the number of tumors 338 in each patient are omitted from the TCGA database, although these two parameters are considered 339 important prognostic factors. Unlike miR-100, no target candidate gene of miR-582 could be identified despite its prognostic significance. It is known that miRNAs can inhibit target genes via 341 degradation of their target mRNAs or by inhibition of translation. If a specific miRNA functions 342 through suppressing translation but not through degrading mRNA, it is difficult to find a target just 343 from miRNA and mRNA expression profiles and their correlation analysis. In the TCGA database, 344 protein expression data are limited compared with miRNA and mRNA data. Therefore, experimental 345 verification is required in the future.
346

Conclusion 347
This study showed that miR-100-5p was underexpressed while miR582-3p was overexpressed to a 348 great extent in HCC tissues with gross VI than that in HCC tissues without gross VI. In addition, their 
